FORA Capital’s Constellation Pharmaceuticals, Inc. CNST Stock Holding History

FORA Capital’s Portfolio CNST Stock Details CNST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-11,984	Closed	-$405K	–	1008
2021 Q2	$405K	Buy	+11,984	New	+$305K	0.08%	302
2021 Q1	–	Sell	-13,567	Closed	-$391K	–	1240
2020 Q4	$391K	Buy	+13,567	New	+$342K	0.06%	334

FORA Capital's CNST Position: Q3 2021 in Review

FORA Capital sold out of Constellation Pharmaceuticals, Inc. (CNST) in Q3 2021, closing a stake of 11,984 shares — an estimated $405K sold.

FORA Capital first reported a position in CNST in Q4 2020 and held it in 2 quarters. The position peaked at $405K in Q2 2021. 0 funds tracked by Wall St. Rank hold CNST as of Q3 2021.

FORA Capital reported no remaining Constellation Pharmaceuticals, Inc. position as of Q3 2021 after selling out during the quarter.
FORA Capital sold 11,984 Constellation Pharmaceuticals, Inc. shares in Q3 2021, an estimated $405K.
FORA Capital first reported a position in Constellation Pharmaceuticals, Inc. in Q4 2020 and held it in 2 quarters.
FORA Capital's Constellation Pharmaceuticals, Inc. position peaked at $405K in Q2 2021.
0 funds tracked by Wall St. Rank held Constellation Pharmaceuticals, Inc. as of Q3 2021.

Based on FORA Capital's 13F filing for Q3 2021, filed 15 Nov 2021.